Improving access to care in the developing world

The Novo Nordisk Haemophilia Foundation (NNHF) was created in 2005 to address the significant need for improving access to care for people with haemophilia and allied bleeding disorders in the developing world where bleeding disorders are currently not a healthcare priority and still today many patients go undiagnosed or are inadequately treated.

NNHF is a non-profit entity, located in Zurich, Switzerland, which funds development programmes and supports better practice sharing.

NNHF programmes include for instance awards, fellowships and projects focusing on capacity building, awareness creation and diagnosis and registries.